[PDF][PDF] Transmembrane 6 superfamily member 2 gene variant disentangles nonalcoholic steatohepatitis from cardiovascular disease

…, S Grimaudo, S Pelusi, T Montalcini, A Alisi… - …, 2015 - Wiley Online Library
Excess hepatic storage of triglycerides is considered a benign condition, but nonalcoholic
steatohepatitis (NASH) may progress to fibrosis and promote atherosclerosis. Carriers of the …

[PDF][PDF] Gut microbiota profiling of pediatric nonalcoholic fatty liver disease and obese patients unveiled by an integrated meta‐omics‐based approach

…, G Capuani, B Dallapiccola, A Miccheli, A Alisi… - …, 2017 - Wiley Online Library
There is evidence that nonalcoholic fatty liver disease (NAFLD) is affected by gut microbiota.
Therefore, we investigated its modifications in pediatric NAFLD patients using targeted …

Global multi-stakeholder endorsement of the MAFLD definition

…, K Ali, BA Ali, M Ali, RAR Ali, A Alisi… - The lancet …, 2022 - thelancet.com
Correspondence 390 www. thelancet. com/gastrohep Vol 7 May 2022 at least two different
mechanisms of action. Views were divided on the failure of immunomodulators, with 252 (56%…

[HTML][HTML] Non-invasive stratification of hepatocellular carcinoma risk in non-alcoholic fatty liver using polygenic risk scores

…, V Borroni, R D'Ambrosio, R Spagnuolo, A Alisi… - Journal of …, 2021 - Elsevier
Background & Aims Hepatocellular carcinoma (HCC) risk stratification in individuals with
dysmetabolism is a major unmet need. Genetic predisposition contributes to non-alcoholic fatty …

Complications, morbidity and mortality of nonalcoholic fatty liver disease

A Mantovani, E Scorletti, A Mosca, A Alisi, CD Byrne… - Metabolism, 2020 - Elsevier
Nonalcoholic fatty liver disease (NAFLD) is an increasingly recognized public health
problem, affecting up to a quarter of the world's adult population. The burden of NAFLD is …

Defining paediatric metabolic (dysfunction)-associated fatty liver disease: an international expert consensus statement

…, D Kelly, G Porta, MA El-Guindi, A Alisi… - The Lancet …, 2021 - thelancet.com
The term non-alcoholic fatty liver disease (NAFLD), and its definition, have limitations for
both adults and children. The definition is most problematic for children, for whom alcohol …

[PDF][PDF] I148M patatin‐like phospholipase domain‐containing 3 gene variant and severity of pediatric nonalcoholic fatty liver disease

L Valenti, A Alisi, E Galmozzi, A Bartuli… - …, 2010 - Wiley Online Library
Nonalcoholic fatty liver disease (NAFLD) is one of the most common causes of chronic liver
disease in children. Genetic variability, which is a main player in NAFLD, is especially …

Docosahexaenoic acid supplementation decreases liver fat content in children with non-alcoholic fatty liver disease: double-blind randomised controlled clinical trial

V Nobili, G Bedogni, A Alisi, A Pietrobattista… - Archives of disease in …, 2011 - adc.bmj.com
Objective To investigate whether dietary supplementation with docosahexaenoic acid (DHA)
decreases liver fat content in children with non-alcoholic fatty liver disease (NAFLD). Design…

NAFLD in children: new genes, new diagnostic modalities and new drugs

V Nobili, A Alisi, L Valenti, L Miele… - Nature reviews …, 2019 - nature.com
Nonalcoholic fatty liver disease (NAFLD) has rapidly become the most common form of
chronic liver disease in children and adolescents. Over the past 5 years, developments have …

Antioxidant effects of natural bioactive compounds

C Balsano, A Alisi - Current pharmaceutical design, 2009 - ingentaconnect.com
Reactive oxygen species (ROS), as well as reactive nitrogen species (RNS) play either
harmful or beneficial role in biological systems. Beneficial effects of ROS include physiological …